Progress report of the Human Rights Council Advisory Committee (A/HRC/33/53) (Advance edited version)
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility testing of yeast
Independent Monitoring Board of the Global Polio Eradication Initiative (Twelfth Report: October 2015)
This toolkit has been developed by the ZAZI campaign for use by peer educators, community outreach workers, faith-based organisations, and traditional health practitioners to help facilitate participatory discussions on sexual and reproductive health with women aged between 20 and 49 years of age. T...he toolkit is divided in 10 content sections
more
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
Early Essential Newborn Care (EENC) Module 2.
Extract from "Essentials of Pharmaceutical Practice - EPP Handbook" by Ecumenical Pharmaceutical Network (EPN) (ISBN 978-9966-094-44-5). Chapter contents: Definition and understanding about SOPs - Importance of SOPs - Role of SOPs in ensuring quality of services in the pharmacy - Developing SOPs fo...r various processes carried out in the pharmacy - Making effective and active use of SOPs.
more
Acclerating attainment of universal health coverage and bridging the access inequity gap
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...rovide primary guidelines to assist health lab personnel in developing countries to establish a PCR diagnostic facility for efficient support to patient care as well as public health actions.
more
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, tim...eline, and process may vary from country to country, this guide presents the broad steps involved in revising an EML for any health commodity. Additional resources and a glossary are included to provide supplemental information and to clarify key terms.
more